First Time Loading...

Modalis Therapeutics Corp
TSE:4883

Watchlist Manager
Modalis Therapeutics Corp Logo
Modalis Therapeutics Corp
TSE:4883
Watchlist
Price: 70 JPY -1.41% Market Closed
Updated: May 16, 2024
Modalis Therapeutics Corp
/
Income Statement
/
Interest Income Expense

Modalis Therapeutics Corp
Interest Income Expense

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Modalis Therapeutics Corp
Interest Income Expense Peer Comparison

Comparables:
2160
4587
4974
2929
S
4599

Competitive Interest Income Expense Analysis
Latest Figures & CAGR of Competitors

Company Interest Income Expense CAGR 3Y CAGR 5Y CAGR 10Y
Modalis Therapeutics Corp
TSE:4883
Interest Income Expense
¥35m
CAGR 3-Years
N/A
CAGR 5-Years
196%
CAGR 10-Years
N/A
GNI Group Ltd
TSE:2160
Interest Income Expense
-¥548.9m
CAGR 3-Years
-105%
CAGR 5-Years
-22%
CAGR 10-Years
-88%
PeptiDream Inc
TSE:4587
Interest Income Expense
-¥2.4B
CAGR 3-Years
-164%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Takara Bio Inc
TSE:4974
Interest Income Expense
¥202m
CAGR 3-Years
26%
CAGR 5-Years
102%
CAGR 10-Years
4%
Pharma Foods International Co Ltd
TSE:2929
Interest Income Expense
-¥66m
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
S
StemRIM Inc
TSE:4599
Interest Income Expense
¥587k
CAGR 3-Years
N/A
CAGR 5-Years
142%
CAGR 10-Years
N/A

See Also

What is Modalis Therapeutics Corp's Interest Income Expense?
Interest Income Expense
35m JPY

Based on the financial report for Dec 31, 2023, Modalis Therapeutics Corp's Interest Income Expense amounts to 35m JPY.

What is Modalis Therapeutics Corp's Interest Income Expense growth rate?
Interest Income Expense CAGR 5Y
196%

Over the last year, the Interest Income Expense growth was -51%.

ALPHA SPREAD
Join more than 137,700+ value investors using Alpha Spread
Create a free account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2024 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.